The Covaxin contract to Brazil landed in controversy after the South American country's Attorney General reportedly launched a probe into the deal.
Photo used for representational purpose. Pic/AFP
The Covaxin contract to Brazil landed in controversy after the South American country's Attorney General reportedly launched a probe into the deal.
"It is noteworthy that the @govbr did not pay ANY CENT for the Covaxin vaccine. The measure does not compromise the pace of the vaccination campaign against #Covid19 in Brazil, since there is no approval from Anvisa for emergency or definitive use of the immunizing agent," Queiroga said in another tweet.
p>This story has been sourced from a third party syndicated feed, agencies. Mid-day accepts no responsibility or liability for its dependability, trustworthiness, reliability and data of the text. Mid-day management/mid-day.com reserves the sole right to alter, delete or remove (without notice) the content in its absolute discretion for any reason whatsoever.
Subscribe today by clicking the link and stay updated with the latest news!" Click here!
